EPILINKS

What EPILINKS does

EPILINKS (legal name Société EPILINKS) is a privately held French consulting agency founded in 2017 and headquartered in Thoiry, on the outskirts of Geneva. The firm is co-led by Isabelle Delrieu (President; PhD in Biology, Master's in Public Health) and Elise Guillermet (Director of Project Implementation; PhD in Anthropology), and operates with a team of 1–10 employees. Its mission is to support equitable access to quality health services for populations in low and middle-income countries by providing contextualized, evidence-based public health solutions through a multi-sectoral approach.

EpiLinks delivers a portfolio of professional services rather than a technology product: technical assistance to countries on public health policy and vaccine introduction planning; development of toolkits, operational guidelines, and communication materials; desk reviews of published and grey literature; capacity building for health personnel; field studies and operational research in epidemiology, anthropology, and biology; and market studies assessing decision-maker interest and end-user acceptability of health products. Engagements span at least 14 countries across Africa (Mauritania, Morocco, Guinea-Bissau, Liberia, Mali, Cameroon, DRC, Mozambique, Benin, Burkina Faso, Côte d'Ivoire), Asia (Uzbekistan), Latin America (Brazil), the Middle East (Lebanon), and Europe (Bosnia and Herzegovina).

The business model is project-based professional services sold directly to multilateral health bodies (WHO, UNICEF, Gavi), pharmaceutical companies (Sanofi Pasteur, Ferring), NGOs and foundations (Action Contre la Faim, Mérieux Foundation, JSI, Wellcome Trust, GaneshAid), and national Ministries of Health. Pricing is negotiated per project and is not publicly disclosed. The firm has no external investment, no parent company, and no disclosed funding rounds, suggesting it is bootstrapped and growth-funded through retained earnings. Go-to-market relies on the founders' scientific credibility, peer-reviewed publications, participation in WHO/UNICEF/Gavi expert meetings, and a lightweight digital presence via LinkedIn, Twitter, and a corporate website.

Name

EPILINKS

Legal name

Société EPILINKS

Website

https://epilinks.net

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

EpiLinks is a French consulting agency that delivers evidence-based public health technical assistance, operational research, capacity building, and implementation support to governments, WHO, UNICEF, Gavi, NGOs, and pharmaceutical companies serving low and middle-income countries.

Ownership category

akta.pro rank

Product category

Global Health Consulting Services

akta.pro primary industry

Digital Epidemiology & Event-Based Surveillance (media/mobility) (HLAJABAJ)

Keywords

• Public health consulting
• Epidemiology consulting services
• Vaccine implementation support
• Health systems strengthening
• Global health strategy

Headquarters

HQ city

Chaux-des-prés

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Technical Consulting Services: EpiLinks generates revenue through consulting engagements with governments, international organizations (WHO, UNICEF, Gavi), foundations, pharmaceutical companies, and NGOs. Projects include technical assistance, capacity building, operational research, evaluation studies, and development of guidelines and tools for public health interventions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

EpiLinks is a French consulting agency that delivers evidence-based public health solutions to governments, international organizations, foundations, and pharmaceutical companies operating in low and middle-income countries. It provides technical assistance in vaccine introduction, disease surveillance, outbreak response, health systems strengthening, capacity building, operational research, and the development of toolkits, guidelines, and market studies.

Product overview

EpiLinks is a consulting agency offering contextualized and evidence-based solutions in public health for low and middle-income countries. Rather than a unified software platform, EpiLinks provides a portfolio of consulting services including technical assistance to countries for public health policy implementation, development of toolkits and operational guidelines, desk reviews and literature analysis, capacity building for health personnel, field studies and operational research, and market studies for health product introduction. The company connects public health actors to develop and implement relevant products, strategies and policies that meet stakeholder needs.

Differentiator

Problem solved

Functional benefit

Products and services

• Public Health Consulting Services

Quantifiable outcome

• Supported Gavi financing applications for malaria vaccine introduction in multiple countries
• +2 more outcomes

Named customers12 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Ten partnerships are on record, tiered core and minor.

• World Health Organization (WHO)coreStrategic or Co-development PartnerEpiLinks provides technical assistance to WHO on various initiatives including meningitis roadmap adaptation, cold chain integration, surveillance systems, and outbreak response. They work with WHO headquarters and regional offices including the South-East Asia Regional Office.
• UNICEFcoreStrategic or Co-development PartnerEpiLinks supports UNICEF on vaccine management initiatives, capacity building programs, and supply chain strengthening projects in various countries.
• Gavi, the Vaccine AlliancecoreStrategic or Co-development PartnerEpiLinks provides technical assistance for Gavi-funded programs including malaria vaccine introduction planning, financing applications, and immunization program support in multiple African countries.
• Sanofi PasteurcoreStrategic or Co-development PartnerEpiLinks supports Sanofi Pasteur with dengue vaccine implementation including expert meetings, toolkit development, and regional implementation guidance in Latin America and Asia Pacific.
• Action Contre la Faim (ACF)coreStrategic or Co-development PartnerEpiLinks developed cholera response standard operating procedures for ACF field teams and provided COVID-19 outbreak response support.
• Mérieux FoundationcoreStrategic or Co-development PartnerEpiLinks participates in expert workshops hosted by the Mérieux Foundation on dengue vaccination and laboratory capacity building in West Africa.
• Ferring PharmaceuticalsminorStrategic or Co-development PartnerEpiLinks developed training resources for Ferring's heat-stable uterotonic (carbetocin) for maternal health in Africa.
• JSI Research & Training InstitutecoreStrategic or Co-development PartnerEpiLinks provided technical support for rotavirus vaccine introduction through JSI's RAVIN project in the Democratic Republic of Congo.
• Wellcome TrustminorStrategic or Co-development PartnerEpiLinks conducted a case study on research data sharing during cholera outbreaks funded by Wellcome Trust.
• GaneshAidminorStrategic or Co-development PartnerEpiLinks supported an economic feasibility study for a regional centre of excellence in health logistics conducted by GaneshAid with Gavi funding.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Management Sciences for Health (MSH): Global nonprofit consultancy strengthening health systems, pharmaceutical management, and immunization programs in low- and middle-income countries. Comparable mandate, donor base, and service portfolio to EpiLinks.
• RTI International: Global research institute delivering infectious disease, immunization, and health systems research and implementation services across LMICs. Comparable on operational research and field-based public health project delivery.
• Clinton Health Access Initiative (CHAI): Global health advisory organization working with governments and multilaterals to expand access to vaccines, medicines, and diagnostics in LMICs. Highly comparable to EpiLinks' mandate of supporting LMIC governments on vaccine introduction, health systems strengthening, and policy implementation.
• BroadReach Group: Healthcare consulting and implementation firm operating across Africa and emerging markets, supporting governments, donors, and multilaterals on health systems and program delivery. Directly comparable LMIC-focused delivery model.
• PATH: Global health nonprofit focused on vaccine introduction, infectious disease, and health systems innovation across LMICs. Overlaps with EpiLinks on vaccine implementation support and operational research for public health interventions.
• ThinkWell: Global health consultancy providing strategic, policy, and implementation support to governments and multilaterals, with strong presence in immunization financing and LMIC health system reform. Closely comparable in scope and client mix to EpiLinks.
• Abt Associates: Global consulting and research firm with a dedicated global health practice delivering immunization, surveillance, and health systems strengthening projects funded by USAID and foundations. Comparable to EpiLinks on LMIC public health delivery.
• John Snow, Inc. (JSI): Public health consulting and research organization delivering immunization, supply chain, and health systems projects in LMICs. EpiLinks is already a subcontractor to JSI on the RAVIN rotavirus project, evidencing direct operational overlap.
• Palladium: International development consultancy with deep global health and monitoring/evaluation practice, serving DFID/USAID, foundations, and multilaterals. Comparable in delivering operational research, M&E, and technical assistance in LMICs.

Broad incumbents

• McKinsey Global Health Practice: Global management consulting firm with a global health practice serving multilaterals, governments, and pharmaceutical companies on health system strategy and policy. Operates in the same donor ecosystem as EpiLinks but at much larger scale and broader scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/EpiLinks2018
• LinkedInfr.linkedin.com/company/epilinks

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EPILINKS